Ilofotase alfa

艾洛弗酶 α

Report date: 2024/10/09 20:00:32

Base Information

Drug NameIlofotase alfa
Drug Alias Name重组碱性磷酸酶 - AM-PharmaHuman recombinant alkaline phosphataseRecombinant optimised human alkaline phosphataserecAP
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEndotoxin inhibitorsEnzyme replacements
TargetsEndotoxin
Therapy Area/IndicationsShockHypophosphatasiaAcute Kidney Injury +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[16] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAM-Pharma BV
China Registration ClassN/A

Develop Information

Active CompaniesKyowa KirinAM-Pharma BV
Inactive CompaniesRadboud University Medical Center
Active IndicationsHypophosphatasia
Inactive IndicationsShockAcute Kidney InjurySepsis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A